Literature DB >> 2286715

Botulinum toxin in treatment of tardive dyskinetic syndrome.

D D Truong, N Hermanowicz, M Rontal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2286715

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  5 in total

Review 1.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

Review 2.  Movement disorders of the mouth: a review of the common phenomenologies.

Authors:  C M Ghadery; L V Kalia; B S Connolly
Journal:  J Neurol       Date:  2022-07-29       Impact factor: 6.682

3.  [Treatment of lingual dystonia with botulinum toxin injections. First report].

Authors:  G Reichel; A Stenner
Journal:  Nervenarzt       Date:  2009-08       Impact factor: 1.214

4.  Treatment of severe neuroleptic-induced tardive torticollis.

Authors:  Beata J Havaki-Kontaxaki; Vassilis P Kontaxakis; Maria M Margariti; Konstantinos G Paplos; George N Christodoulou
Journal:  Ann Gen Hosp Psychiatry       Date:  2003-10-17

5.  Botulinum Toxin Type A Injection for Cervical Dystonia in Adults with Dyskinetic Cerebral Palsy.

Authors:  You Gyoung Yi; Keewon Kim; Youbin Yi; Young-Ah Choi; Ja-Ho Leigh; Moon Suk Bang
Journal:  Toxins (Basel)       Date:  2018-05-16       Impact factor: 4.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.